PRIME PubMed | Quality improvement review of O positive blood in emergency transfusion (2024)

PRIME PubMed

Type your tag names separated by a space and hit enter

PRIME PubMed | Quality improvement review of O positive blood in emergency transfusion (1)

Abstract

BACKGROUND

We recently introduced a policy to use O positive red cells in emergency transfusions for males >16 years of age and females >50 years of age. Here, we investigate changes in emergency transfusion practice and rates of red cell alloimmunization with the use of O positive blood for emergency transfusion.

STUDY DESIGN AND METHODS

State-wide retrospective review of emergency transfusions between June 2020 and June 2021. The laboratory information system and patient medical records were used to collect demographic details, indications for transfusion, usage of O positive and O negative blood and rates of alloimmunization.

RESULTS

There were 2354 red cell units transfused to 1013 patients (male = 59%, average age = 53 years) during the 12-month period. O positive units accounted for 46.9% (1103 units) of emergency transfusions. However, 726 (30.8%) O negative units were transfused to patients without a mandatory indication for O negative blood. Twenty-eight patients (2.9%) had a red cell alloantibody prior to transfusion including anti-E (n = 10), anti-D (n = 4), and anti-K (n = 4). One patient with prior anti-D had mild delayed hemolysis. There were 19 patients (4.3%, median follow-up 22 days) who developed a red cell alloantibody after emergency transfusion and include anti-E (n = 10), anti-D (n = 7), and anti-C (n = 5).

DISCUSSION

The use of O positive blood for emergency transfusion has saved 1103 O negative red cell units with no detriment to patient outcome. There remains potential to optimize use of O positive blood in emergency transfusion and to understand red cell alloimmunization rates in a prospective fashion.

Authors+Show Affiliations

Chowdhury R

Princess Alexandra Hospital, Pathology Queensland, Brisbane, Australia.

Williams BA

Central Pathology Laboratory (Royal Brisbane and Women's Hospital), Pathology Queensland, Brisbane, Australia.

Williams S

Central Pathology Laboratory (Royal Brisbane and Women's Hospital), Pathology Queensland, Brisbane, Australia.

Casey J

Townsville University Hospital, Pathology Queensland, Townsville, Australia.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

37698202

Citation

Chowdhury, Rakin, et al. "Quality Improvement Review of O Positive Blood in Emergency Transfusion." Transfusion, vol. 63, no. 10, 2023, pp. 1841-1848.

Chowdhury R, Williams BA, Williams S, et al. Quality improvement review of O positive blood in emergency transfusion. Transfusion. 2023;63(10):1841-1848.

Chowdhury, R., Williams, B. A., Williams, S., & Casey, J. (2023). Quality improvement review of O positive blood in emergency transfusion. Transfusion, 63(10), 1841-1848. https://doi.org/10.1111/trf.17537

Chowdhury R, et al. Quality Improvement Review of O Positive Blood in Emergency Transfusion. Transfusion. 2023;63(10):1841-1848. PubMed PMID: 37698202.

* Article titles in AMA citation format should be in sentence-case

TY - JOURT1 - Quality improvement review of O positive blood in emergency transfusion.AU - Chowdhury,Rakin,AU - Williams,Bronwyn A,AU - Williams,Sue,AU - Casey,John,Y1 - 2023/09/12/PY - 2023/07/08/revisedPY - 2023/02/23/receivedPY - 2023/07/28/acceptedPY - 2023/9/12/pubmedPY - 2023/9/12/medlinePY - 2023/9/12/entrezKW - O positiveKW - emergencyKW - red cellsKW - transfusionSP - 1841EP - 1848JF - TransfusionJO - TransfusionVL - 63IS - 10N2 - BACKGROUND: We recently introduced a policy to use O positive red cells in emergency transfusions for males >16 years of age and females >50 years of age. Here, we investigate changes in emergency transfusion practice and rates of red cell alloimmunization with the use of O positive blood for emergency transfusion. STUDY DESIGN AND METHODS: State-wide retrospective review of emergency transfusions between June 2020 and June 2021. The laboratory information system and patient medical records were used to collect demographic details, indications for transfusion, usage of O positive and O negative blood and rates of alloimmunization. RESULTS: There were 2354 red cell units transfused to 1013 patients (male = 59%, average age = 53 years) during the 12-month period. O positive units accounted for 46.9% (1103 units) of emergency transfusions. However, 726 (30.8%) O negative units were transfused to patients without a mandatory indication for O negative blood. Twenty-eight patients (2.9%) had a red cell alloantibody prior to transfusion including anti-E (n = 10), anti-D (n = 4), and anti-K (n = 4). One patient with prior anti-D had mild delayed hemolysis. There were 19 patients (4.3%, median follow-up 22 days) who developed a red cell alloantibody after emergency transfusion and include anti-E (n = 10), anti-D (n = 7), and anti-C (n = 5). DISCUSSION: The use of O positive blood for emergency transfusion has saved 1103 O negative red cell units with no detriment to patient outcome. There remains potential to optimize use of O positive blood in emergency transfusion and to understand red cell alloimmunization rates in a prospective fashion. SN - 1537-2995UR - https://www.unboundmedicine.com/medline/citation/37698202/Quality_improvement_review_of_O_positive_blood_in_emergency_transfusion.DB - PRIMEDP - Unbound MedicineER -

Try the Free App:

Prime PubMed is provided
free to individuals by:
Unbound Medicine.

Related Citations

  • Anti-D Alloimmunization After RhD Positive Red Cell Transfusion to Selected RhD Negative Patients.
  • Alloimmunization in transfused patients with constitutional anemias in Norway.
  • Red blood cell alloimmunization among hospitalized patients: transfusion reactions and low alloantibody identification rate.
  • Emergency transfusion of patients with unknown blood type with blood group O Rhesus D positive red blood cell concentrates: a prospective, single-centre, observational study.
  • Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.
  • Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt.
  • Detection and identification of red cell alloantibodies in multiply transfused thalassemia major patients: a prospective study.
  • Transfusion of older red blood cell units, cytokine burst and alloimmunization: a case-control study.
  • Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients.
  • Predictors of Red Cell Alloimmunization in Kurdish Multi Transfused Patients with Hemoglobinopathies in Iraq.

More

PRIME PubMed | Quality improvement review of O positive blood in emergency transfusion (2024)
Top Articles
Latest Posts
Article information

Author: Jamar Nader

Last Updated:

Views: 6231

Rating: 4.4 / 5 (75 voted)

Reviews: 82% of readers found this page helpful

Author information

Name: Jamar Nader

Birthday: 1995-02-28

Address: Apt. 536 6162 Reichel Greens, Port Zackaryside, CT 22682-9804

Phone: +9958384818317

Job: IT Representative

Hobby: Scrapbooking, Hiking, Hunting, Kite flying, Blacksmithing, Video gaming, Foraging

Introduction: My name is Jamar Nader, I am a fine, shiny, colorful, bright, nice, perfect, curious person who loves writing and wants to share my knowledge and understanding with you.